Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

Glycaemia and correlates of patient-reported outcomes in ACCORD trial participants.

Ali MK, Feeney P, Hire D, Simmons DL, O'Connor PJ, Ganz-Lord F, Goff D Jr, Zhang P, Anderson RT, Narayan KM, Sullivan MD.

Diabet Med. 2012 Jul;29(7):e67-74. doi: 10.1111/j.1464-5491.2011.03532.x.

PMID:
22141437
2.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
3.

Intensive glucose control and cardiovascular outcomes in type 2 diabetes.

Macisaac RJ, Jerums G.

Heart Lung Circ. 2011 Oct;20(10):647-54. doi: 10.1016/j.hlc.2010.07.013. Epub 2010 Aug 31. Review.

PMID:
20807681
4.

Health-related quality of life, disease severity, and anticipated trajectory of diabetes.

Scollan-Koliopoulos M, Bleich D, Rapp KJ, Wong P, Hofmann CJ, Raghuwanshi M.

Diabetes Educ. 2013 Jan-Feb;39(1):83-91. doi: 10.1177/0145721712467697. Epub 2012 Nov 21. Review.

PMID:
23174664
5.

Aiming for better glucose control: is HbA(1c) of 7% the 'holy grail'? The clinical approach or seven clinical questions about 7.

Koren S, Rapoport MJ.

Diabetes Metab Res Rev. 2014 Jul;30(5):346-9. doi: 10.1002/dmrr.2532. Review.

PMID:
24510443

Supplemental Content

Write to the Help Desk